Gregory M. Weinhoff, Chief Business Officer at Centessa Pharmaceuticals plc (CNTA), sold 146,392 shares at $26.17 ($3.9M) on 2026-03-13, disclosed to the SEC on 2026-03-13.
Open-market sale of $3.9M CNTA by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.17 | 61,253 | $1.6M | 41.6% |
| 2 | $26.17 | 61,253 | $1.6M | 41.6% |
| 3 | $27.16 | 11,943 | $324K | 8.4% |
| 4 | $27.16 | 11,943 | $324K | 8.4% |
| Total | $26.33 avg | 146,392 | $3.9M | 100% |
| Filing → |
| CNTA | SELL | 2025-06-25 | $139K | — | Filing → |
| CNTA | SELL | 2025-05-27 | $128K | — | Filing → |
| CNTA | SELL | 2025-04-25 | $320K | — | Filing → |